Showing 1 - 7 of 7
Il presente lavoro delinea un quadro dettagliato sulla Teoria dell'Utilità Attesa (EUT) e descrive le maggiori critiche che nel corso degli anni sono nate su di essa. Troviamo il Paradosso di Allais, la Regret Theory, Il Paradosso di Ellsberg, Disappointment theory, l'apporto di Savage, la Risk...
Persistent link: https://www.econbiz.de/10013107573
This paper aims at analyzing the main aspects related to the pricing of credit in the traditional channel, and that of microcredit. After a brief introduction of the concept of microcredit, we analyze the main differences between the two channels of credit
Persistent link: https://www.econbiz.de/10014172288
The present work has the task of developing an analysis of the eco-label, which is the environmentally conscious corporate philosophy. We analyze the different possibilities of modification of the product used by companies to come in against the needs of its customers, in a policy environment
Persistent link: https://www.econbiz.de/10014038690
The present work has the task of developing an analysis of the main methods of estimating WTP, Willingness To Pay, for the evaluation of projects related to renewable energy, such as open-ended method, choices dichotomous, auctions, payment cards with a range of prices
Persistent link: https://www.econbiz.de/10014038692
This paper outlines a detailed evaluation of intangible assets within the company, now more and more important and fundamental. It focuses on these resources through the use of direct valuation methods (scored card, Tobin's Q ratio, VAIC, interbrand, technology brokers), historical cost,...
Persistent link: https://www.econbiz.de/10013109750
In this paper we take the subject in the methods of business valuation. Starting with a brief introduction about the uncertainty evaluation, we review the operating lease, income-based method, mixed, ending with the empirical ones, highlighting the advantages and disadvantages of each
Persistent link: https://www.econbiz.de/10013110494
The present work has not the task of developing a discussion of the main methods and criteria in evaluating the company, but wants to focus on the evaluation of pharmaceutical companies. from a difference in size of pharmaceutical companies, we will focus on issues such time period, intangible...
Persistent link: https://www.econbiz.de/10013110808